The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of tumor immune infiltrate as a determinant of response to neo-adjuvant lapatinib and trastuzumab (LT) in HER2-positive (+) breast cancer (BC).
 
Carmine De Angelis
No Relationships to Disclose
 
Chandandeep Nagi
No Relationships to Disclose
 
Cliff Hoyt
Employment - Perkin Elmer
Stock and Other Ownership Interests - Gilead Sciences
 
Liu Linying
Employment - Perkin Elmer
 
Kristin Roman
Stock and Other Ownership Interests - Gilead Sciences (I)
 
Chichung Wang
Employment - Perkin Elmer
 
Yi Zheng
Employment - Perkin Elmer
 
Tao Wang
No Relationships to Disclose
 
Rena Mao
No Relationships to Disclose
 
Susan G. Hilsenbeck
No Relationships to Disclose
 
Carolina Gutierrez
No Relationships to Disclose
 
Antonio C. Wolff
Honoraria - Medscape
Consulting or Advisory Role - Mersana
Research Funding - Myriad Genetics
Patents, Royalties, Other Intellectual Property - JHU Reference C12014: A Quantitative Multiplex Methylation Specific PCR Method-cMethDNA, Reagents, and Its Use
 
C. Kent Osborne
Stock and Other Ownership Interests - Genetex
Honoraria - AstraZeneca; bioTheranostics; Genentech; NanoString Technologies; Novartis; Perkin Elmer
Research Funding - AstraZeneca
Patents, Royalties, Other Intellectual Property - Lippincott
Travel, Accommodations, Expenses - AstraZeneca; bioTheranostics; Genentech; NanoString Technologies; Novartis; Perkin Elmer
 
Mothaffar F. Rimawi
Consulting or Advisory Role - Celgene
Research Funding - GlaxoSmithKline (Inst)
 
Rachel Schiff
Research Funding - AstraZeneca